These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2155306)

  • 1. Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come.
    Ettinger DS
    J Clin Oncol; 1990 Mar; 8(3):374-7. PubMed ID: 2155306
    [No Abstract]   [Full Text] [Related]  

  • 2. New perspectives in lung cancer.5. New drugs in lung cancer.
    Talbot DC; Smith IE
    Thorax; 1992 Mar; 47(3):188-94. PubMed ID: 1325676
    [No Abstract]   [Full Text] [Related]  

  • 3. Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory.
    Jensen PB; Sehested M; Langer SW; Hansen HH
    Cancer Treat Rev; 1999 Dec; 25(6):377-86. PubMed ID: 10644503
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
    Evans WK; Eisenhauer EA; Cormier Y; Ayoub J; Wierzbicki R; Laberge F; Shepherd FA
    J Clin Oncol; 1990 Mar; 8(3):390-5. PubMed ID: 2155309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in chemotherapy treatment of small-cell lung cancer.
    Johnson DH
    Semin Oncol; 1993 Aug; 20(4):315-25. PubMed ID: 8393591
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatments for small cell lung cancer. When to test.
    Smith IE
    Chest; 1989 Jul; 96(1 Suppl):59S-61S. PubMed ID: 2544363
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating new drugs as first treatment in patients with small-cell carcinoma: guidelines for an ethical approach with implications for other chemotherapy-sensitive tumors.
    Cullen MH; Hilton C; Stuart NS
    J Clin Oncol; 1988 Aug; 6(8):1356-7. PubMed ID: 2842466
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of carbetimer in non-small cell lung cancer.
    Keaton M; Brown T; Craig J; Fries G; Harmon G; Zaloznik A; Orczyk G; Von Hoff D
    Invest New Drugs; 1990 Nov; 8(4):385-6. PubMed ID: 1964676
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer.
    Baselga J; Kris MG; Scher HI; Phillips M; Heelan RT
    Invest New Drugs; 1993 Feb; 11(1):85-6. PubMed ID: 8394297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polyamines in the evaluation of the effectiveness of cancer patient treatment].
    Bassalyk LS; Nemtsova MP; Merabishvili NV; Tevzadze TA; Korbukh IA
    Vestn Akad Med Nauk SSSR; 1982; (3):57-61. PubMed ID: 6283759
    [No Abstract]   [Full Text] [Related]  

  • 11. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer.
    Ettinger DS
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):27-9. PubMed ID: 11479894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teaching old drugs new tricks raises hopes of new treatment for lung cancer.
    Maurice J
    Lancet Respir Med; 2013 Nov; 1(9):677. PubMed ID: 24429265
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II evaluation of triazinate in patients with metastatic lung cancer.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
    Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
    [No Abstract]   [Full Text] [Related]  

  • 14. Vinorelbine treatment IND program announced.
    Am J Hosp Pharm; 1994 Sep; 51(17):2087. PubMed ID: 7755700
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs in the Pipeline: Non-Small-Cell Lung Cancer.
    Saleh N
    Oncology (Williston Park); 2019 Sep; 33(9):. PubMed ID: 31571181
    [No Abstract]   [Full Text] [Related]  

  • 16. New drugs in small cell lung cancer.
    Thatcher N
    Suppl Tumori; 2002; 1(4):S26-7. PubMed ID: 12415811
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of sulofenur (LY186641) in untreated patients with extensive small cell lung cancer.
    Shepherd FA; MacCormick R; Eisenhauer EA
    Ann Oncol; 1991; 2(10):772-3. PubMed ID: 1666298
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
    Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
    Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phase II study of lung cancer--evaluation of new drug in small cell lung cancer (SCLC) and phase II testing of analogues].
    Furuse K
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1499-503. PubMed ID: 1649580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.